A detailed history of Advisor Group Holdings, Inc. transactions in Exicure, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 289 shares of XCUR stock, worth $92. This represents 0.0% of its overall portfolio holdings.

Number of Shares
289
Previous 289 -0.0%
Holding current value
$92
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.37 - $0.75 $52 - $107
-143 Reduced 33.1%
289 $0
Q3 2023

Nov 13, 2023

BUY
$0.71 - $1.36 $101 - $194
143 Added 49.48%
432 $0
Q2 2023

Aug 10, 2023

SELL
$0.85 - $1.44 $1,331 - $2,255
-1,566 Reduced 84.42%
289 $0
Q3 2022

Nov 14, 2022

BUY
$1.53 - $2.5 $2,142 - $3,500
1,400 Added 307.69%
1,855 $2,000
Q2 2022

Aug 10, 2022

BUY
$2.16 - $6.36 $982 - $2,893
455 New
455 $0

Others Institutions Holding XCUR

About EXICURE, INC.


  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $1.59M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.